Osteonecrosis of the jaws (ONJ), also called “dead jawbone,” is a complication of bisphosphonate (BP) and denosumab treatment of osteoporosis. The first cases associated with bisphosphonate were reported in 2003, and in recent years a significant knowledge has evolved. The incidence is low, but those affected may suffer from pain, loss of gums and teeth, and thus significant loss of masticatory function. This chapter gives an overview of classification as it relates to epidemiology and of the epidemiology of this important condition.
CITATION STYLE
Schiødt, M. (2015). Epidemiology of osteonecrosis of the Jaws from antiresorptive treatment. In The Duration and Safety of Osteoporosis Treatment: Anabolic and Antiresorptive Therapy (pp. 185–192). Springer International Publishing. https://doi.org/10.1007/978-3-319-23639-1_13
Mendeley helps you to discover research relevant for your work.